Norsk Hydro
5.10.2026 19:00:00 CEST | Globenewswire | Press release
Norsk Hydro: Update on Alunorte gas supply situation
Norsk Hydro: Update on Alunorte gas supply situation
Hydro provides an update on the natural gas supply situation at the Alunorte alumina refinery.
Alunorte was informed in August 2026 by its supplier CELBA of disruptions to natural gas availability. Consequently, Alunorte has not received contracted gas deliveries and is currently sourcing gas in the market at spot based prices. Alunorte is in parallel progressing a long-term gas supply solution on competitive terms.
Hydro reported on the potential financial and production impact for the third quarter of 2026 in mid-August this year, estimating a lost alumina production of 100,000 to 120,000 tonnes and a financial impact of USD 75 to 100 million for Bauxite & Alumina. For the fourth quarter of 2026, the estimated cost impact of the difference between contract price and spot based gas prices for Alunorte is between USD 90-110 million.
Alunorte does not expect further interruption to gas supply as a result of the current situation and continues to manage the matter in close collaboration with infrastructure owner CELBA and the relevant authorities.
The financial impact remains uncertain and is subject to gas prices, contractual developments, and the implementation of a long-term solution.
Alunorte is also pursuing available legal remedies and other measures to protect its contractual rights and interests under the existing gas supply agreement.
Investor contact:
Gerd Aalborg Aas
+47 913 05 534
Valentina Gandolfi
+47 958 82 355
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Chemometec A/S5.10.2026 21:52:21 CEST | Press release
Major shareholder announcement - BlackRock, Inc.
Chemometec A/S5.10.2026 21:52:21 CEST | Pressemeddelelse
Storaktionærmeddelelse - BlackRock, Inc.
Tryg A/S5.10.2026 21:21:26 CEST | Pressemeddelelse
Storaktionærmeddelelse
Tryg A/S5.10.2026 21:21:26 CEST | Press release
Major Shareholder Announcement
Genmab A/S5.10.2026 20:49:00 CEST | Press release
Genmab and AbbVie Announce Epcoritamab in Combination with R-CHOP Demonstrates Statistically Significant Improvement in Progression-Free Survival in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom